BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL
The review presented the importance of carvedilol using in terms of renoprotection in renal dysfunction at the pre-dialysis stage of the disease in order to reduce the risk of progression of chronic kidney diseases (CKD) and the development of cardiovascular complications. Immune and non-immune mech...
Main Authors: | I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov |
---|---|
Format: | Article |
Language: | English |
Published: |
Stolichnaya Izdatelskaya Kompaniya
2017-07-01
|
Series: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Subjects: | |
Online Access: | https://www.rpcardio.com/jour/article/view/1496 |
Similar Items
-
Carvedilol(dilatrend) treatment in cardiac failure
by: O M Drapkina, et al.
Published: (2004-12-01) -
Long-term carvedilol therapy effects on left ventricular remodeling and glycemia in patients with chronic heart failure and Type 2 diabetes mellitus
by: R. R. Samedov, et al.
Published: (2008-02-01) -
Efficacy and safety of the first made in Russia alpha, beta long-acting adrenoblocker proxodolol in patients with arterial hypertension of the second degree
by: S A Belyaeva, et al.
Published: (2011-04-01) -
ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES
by: E. I. Bambysheva, et al.
Published: (2016-01-01) -
Cardioselective beta-adrenoreceptor blockade with betaxolol in cardiovascular therapy
by: D. V. Duplyakov
Published: (2009-08-01)